Opaganib potentially minimizes likelihood of resistance due to viral mutations by targeting a human cell component involved in viral replication ... Dec 22
US FDA approved for the first-line treatment of adults with malignant pleural mesothelioma that cannot be removed by surgery... Oct 05
Five-year open-label extension study shows patients continued to experience a sustained benefit; Aimovig maintained a consistent safety profile ... Oct 03
The pharma co. believes that FSD201 may have the potential to address the over-exuberant inflammatory response characterized by COVID-19 infection... Oct 02
Face masks and reusable PPE created using Thermaissance technology Is successfully inactivating coronavirus and pneumonia ... Oct 01
NeuroRx and Relief Therapeutics establish supply and distribution agreements for RLF-100 (aviptadil) ... Oct 01
India’s heart care gets a big boost with world’s most clinically validated personal ECG device ... Sep 25
-Advertisements-
.jpeg)
Saturday, April 05, 2025
.jpeg)
.jpeg)
.jpeg)
.jpeg)
